DiaMedica Therapeutics Inc (DMAC) — Cash Flow-to-Debt Ratio
DiaMedica Therapeutics Inc (DMAC) has a Cash Flow-to-Debt Ratio of -1.55x as of March 2026, meaning its operating cash flow of $-9.08 Million could theoretically repay -2% of its total liabilities ($5.84 Million) in one year. See DiaMedica Therapeutics Inc (DMAC) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
DiaMedica Therapeutics Inc Cash Flow-to-Debt Ratio (2004–2025)
Historical debt coverage capacity for DiaMedica Therapeutics Inc across 22 annual periods. Also explore DiaMedica Therapeutics Inc net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for DiaMedica Therapeutics Inc (2004–2025)
Year-by-year debt coverage analysis for DiaMedica Therapeutics Inc. For market capitalisation and broader financial context, see DiaMedica Therapeutics Inc market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -5.53x | $-29.06 Million | $5.26 Million | ▼ -40.8% |
| 2024 | -3.92x | $-22.08 Million | $5.63 Million | ▲ +35.0% |
| 2023 | -6.04x | $-18.73 Million | $3.10 Million | ▼ -34.6% |
| 2022 | -4.48x | $-11.51 Million | $2.57 Million | ▲ +44.1% |
| 2021 | -8.02x | $-12.25 Million | $1.53 Million | ▼ -81.8% |
| 2020 | -4.41x | $-9.19 Million | $2.08 Million | ▲ +30.4% |
| 2019 | -6.34x | $-9.10 Million | $1.44 Million | ▼ -46.2% |
| 2018 | -4.33x | $-5.70 Million | $1.31 Million | ▼ -11.5% |
| 2017 | -3.89x | $-3.90 Million | $1.00 Million | ▲ +19.4% |
| 2016 | -4.82x | $-3.02 Million | $626.97K | ▼ -412.5% |
| 2015 | -0.94x | $-1.37 Million | $1.45 Million | ▲ +54.6% |
| 2014 | -2.07x | $-3.76 Million | $1.81 Million | ▲ +42.5% |
| 2013 | -3.61x | $-5.50 Million | $1.52 Million | ▼ -4.2% |
| 2012 | -3.47x | $-5.48 Million | $1.58 Million | ▲ +63.2% |
| 2011 | -9.42x | $-3.44 Million | $364.56K | ▼ -119.7% |
| 2010 | -4.29x | $-2.38 Million | $554.10K | ▲ +60.5% |
| 2009 | -10.85x | $-2.15 Million | $197.87K | ▼ -61.3% |
| 2008 | -6.73x | $-1.47 Million | $218.01K | ▼ -51.0% |
| 2007 | -4.45x | $-1.21 Million | $272.38K | ▲ +70.4% |
| 2006 | -15.04x | $-801.16K | $53.27K | ▼ -2.2% |
| 2005 | -14.71x | $-831.17K | $56.49K | ▼ -18803.4% |
| 2004 | -0.08x | $-99.35K | $1.28 Million | — |